Published in J Cardiovasc Electrophysiol on May 15, 2009
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Funny channel gene mutations associated with arrhythmias. J Physiol (2013) 1.00
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol (2016) 0.89
HCN4, Sinus Bradycardia and Atrial Fibrillation. Arrhythm Electrophysiol Rev (2015) 0.78
Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes. Oncotarget (2016) 0.75
Improvements In AF Ablation Outcome Will Be Based More On Technological Advancement Versus Mechanistic Understanding. J Atr Fibrillation (2014) 0.75
The variability of the electrical properties of the pulmonary veins. J Cardiovasc Electrophysiol (2009) 0.75
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 6.58
NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol (2009) 3.18
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J (2003) 3.06
Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke (2012) 2.27
Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 2.25
Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment. Cancer (2008) 2.19
Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation (2003) 2.17
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium. Circ Arrhythm Electrophysiol (2012) 2.01
Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol (2002) 1.87
CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol (2011) 1.77
Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. Europace (2012) 1.75
Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm (2012) 1.65
Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol (2011) 1.60
Colon cancer, version 3.2014. J Natl Compr Canc Netw (2014) 1.59
Paradoxical long-term proarrhythmic effects after ablating the "head station" ganglionated plexi of the vagal innervation to the heart. Heart Rhythm (2013) 1.59
Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med (2010) 1.57
Maneuvers to decrease laparoscopy-induced shoulder and upper abdominal pain: a randomized controlled study. Arch Surg (2011) 1.56
Frequency analysis in different types of paroxysmal atrial fibrillation. J Am Coll Cardiol (2006) 1.56
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int J Cardiol (2013) 1.56
Effects of aging and ouabain on left atrial arrhythmogenicity. J Cardiovasc Electrophysiol (2007) 1.55
Electrophysiology of pulmonary veins. J Cardiovasc Electrophysiol (2006) 1.54
Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace (2012) 1.53
The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J Cardiovasc Electrophysiol (2006) 1.53
Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy. J Cardiovasc Electrophysiol (2012) 1.52
CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol (2012) 1.51
Progressive remodeling of the atrial substrate--a novel finding from consecutive voltage mapping in patients with recurrence of atrial fibrillation after catheter ablation. J Cardiovasc Electrophysiol (2006) 1.49
Rectal cancer. J Natl Compr Canc Netw (2012) 1.49
Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors. J Chin Med Assoc (2011) 1.48
Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.47
Morphological changes of the left atrial appendage after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.47
Acute effect of circumferential pulmonary vein isolation on left atrial substrate. J Cardiovasc Electrophysiol (2009) 1.46
Prevention of postlaparoscopic shoulder and upper abdominal pain: a randomized controlled trial. Obstet Gynecol (2013) 1.45
Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2005) 1.45
Validation of the frequency spectra obtained from the noncontact unipolar electrograms during atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.45
High-resolution mapping around the crista terminalis during typical atrial flutter: new insights into mechanisms. J Cardiovasc Electrophysiol (2004) 1.45
Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score. Heart Rhythm (2012) 1.44
A novel finding- impairment of gastric myoelectricity after catheter ablation of atrial fibrillation. Circ J (2013) 1.43
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2014) 1.43
A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study. J Chin Med Assoc (2007) 1.41
Heart failure enhances arrhythmogenesis in pulmonary veins. Clin Exp Pharmacol Physiol (2011) 1.41
Relationship between arrhythmogenic pulmonary veins and the surrounding atrial substrate in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2010) 1.41
Heat-stress responses modulate beta-adrenergic agonist and angiotensin II effects on the arrhythmogenesis of pulmonary vein cardiomyocytes. J Cardiovasc Electrophysiol (2011) 1.39
Unusual phenomenon of spontaneous termination of atrioventricular nodal reentrant tachycardia with 2:1 atrioventricular block. J Cardiovasc Electrophysiol (2003) 1.39
A prospective, randomized comparison of modified pulmonary vein isolation versus conventional pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2012) 1.39
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis. Circ J (2016) 1.39
Paradoxical aging changes of the atrioventricular nodal properties in patients with atrioventricular nodal re-entrant tachycardia. Circ J (2011) 1.39
Noncontact three-dimensional mapping guides catheter ablation of difficult atrioventricular nodal reentrant tachycardia. Int J Cardiol (2006) 1.39
Mechanism of adenosine-induced termination of focal atrial tachycardia. J Cardiovasc Electrophysiol (2004) 1.38
Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors. Heart Rhythm (2013) 1.38
Electrophysiological characteristics and catheter ablation in patients with paroxysmal right atrial fibrillation. Circulation (2005) 1.31
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.31
Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol (2004) 1.20
The results of radiofrequency catheter ablation of supraventricular tachycardia in children. Pacing Clin Electrophysiol (2007) 1.20
Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw (2005) 1.19
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.17
Consistency of complex fractionated atrial electrograms during atrial fibrillation. Heart Rhythm (2008) 1.17
Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation. J Am Coll Cardiol (2005) 1.17
Mechanism mediating oligomeric Aβ clearance by naïve primary microglia. Neurobiol Dis (2011) 1.17
Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2002) 1.17
Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev (2010) 1.17
Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol (2012) 1.17
Cardiovascular imaging in the management of atrial fibrillation. J Am Coll Cardiol (2006) 1.15
Focal atrial tachycardia: new insight from noncontact mapping and catheter ablation. Circulation (2003) 1.15
Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation. Basic Res Cardiol (2002) 1.14
Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation. Circ Arrhythm Electrophysiol (2013) 1.14
Efficacy of additional ablation of complex fractionated atrial electrograms for catheter ablation of nonparoxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.13
Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fibrillation: insight from long-term follow-up of three-dimensional magnetic resonance imaging. J Cardiovasc Electrophysiol (2005) 1.12
Biatrial substrate properties in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.12